We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The new vaccine from HIPRA Human Health has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Documents relating to the new coronavirus (COVID-19) vaccination programme.
People at greatest risk of serious illness from COVID-19 are eligible for a vaccine.
MHRA scientific and regulatory advice for COVID-19 vaccine developers
The offer of a first or second dose of COVID-19 vaccine will end on 30 June 2023 for most people.
These documents show the vaccines, product names and packaging to compliment the routine immunisation schedule.
The aim is to develop a vaccine that provides cross-protection against the whole genus, addressing outbreaks, and enhancing epidemic preparedness.
Information on the presentation, doses and storage of COVID-19 vaccines.
Information for health professionals and immunisation practitioners.
Apply to manufacture Extemporaneous preparations, Autogenous vaccines, authorisations for Equine Stem Cell Centre (ESCCA) or Non-Food Animal Blood Bank (NFABBA).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.